Global Prevalence and Major Risk Factors of Diabetic Retinopathy.


Yau, JW; Rogers, SL; Kawasaki, R; Lamoureux, EL; Kowalski, JW; Bek, T; Chen, SJ; Dekker, JM; Fletcher, A; Grauslund, J; Haffner, S; Hamman, RF; Ikram, MK; Kayama, T; Klein, BE; Klein, R; Krishnaiah, S; Mayurasakorn, K; O'Hare, JP; Orchard, TJ; Porta, M; Rema, M; Roy, MS; Sharma, T; Shaw, J; Taylor, H; Tielsch, JM; Varma, R; Wang, JJ; Wang, N; West, S; Xu, L; Yasuda, M; Zhang, X; Mitchell, P; Wong, TY; for the Meta-Analysis for Eye Disease (META-EYE) Study Group, ; (2012) Global Prevalence and Major Risk Factors of Diabetic Retinopathy. Diabetes care, 35 (3). pp. 556-564. ISSN 0149-5992 DOI: https://doi.org/10.2337/dc11-1909

[img]
Preview
Text - Published Version
License:

Download (166kB) | Preview
[img]
Preview
Text - Supplemental Material
License:

Download (112kB) | Preview

Abstract

: OBJECTIVE To examine the global prevalence and major risk factors for diabetic retinopathy (DR) and vision-threatening diabetic retinopathy (VTDR) among people with diabetes. RESEARCH DESIGN AND METHODS A pooled analysis using individual participant data from population-based studies around the world was performed. A systematic literature review was conducted to identify all population-based studies in general populations or individuals with diabetes who had ascertained DR from retinal photographs. Studies provided data for DR end points, including any DR, proliferative DR, diabetic macular edema, and VTDR, and also major systemic risk factors. Pooled prevalence estimates were directly age-standardized to the 2010 World Diabetes Population aged 20-79 years. RESULTS A total of 35 studies (1980-2008) provided data from 22,896 individuals with diabetes. The overall prevalence was 34.6% (95% CI 34.5-34.8) for any DR, 6.96% (6.87-7.04) for proliferative DR, 6.81% (6.74-6.89) for diabetic macular edema, and 10.2% (10.1-10.3) for VTDR. All DR prevalence end points increased with diabetes duration, hemoglobin A(1c), and blood pressure levels and were higher in people with type 1 compared with type 2 diabetes. CONCLUSIONS There are approximately 93 million people with DR, 17 million with proliferative DR, 21 million with diabetic macular edema, and 28 million with VTDR worldwide. Longer diabetes duration and poorer glycemic and blood pressure control are strongly associated with DR. These data highlight the substantial worldwide public health burden of DR and the importance of modifiable risk factors in its occurrence. This study is limited by data pooled from studies at different time points, with different methodologies and population characteristics.

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Non-Communicable Disease Epidemiology
PubMed ID: 22301125
Web of Science ID: 300801400021
URI: http://researchonline.lshtm.ac.uk/id/eprint/55254

Statistics


Download activity - last 12 months
Downloads since deposit
3,460Downloads
475Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item